Posner Christopher
SEC CIK 1748265 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TVRD | Tvardi Therapeutics, Inc. | Pres, CEO, Dir | 13.1K | — | $365.7K | 18 | 2021-10-29 | 2025-02-28 |
Most active insiders at TVRD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Posner Christopher made no open-market trades at TVRD in the last 12 months.
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-04 | 2025-02-28 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres AND CEO, Dir | S - Sale | $4.75 | -583 | 13.1K | -4% | -$2,769 | |
| 2025-02-06 | 2025-02-04 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres AND CEO, Dir | S - Sale | $4.72 | -372 | 13.7K | -3% | -$1,756 | |
| 2024-11-06 | 2024-11-04 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres AND CEO, Dir | S - Sale | $0.29 | -3,668 | 168.8K | -2% | -$1,064 | |
| 2024-08-02 | 2024-08-01 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres AND CEO, Dir | S - Sale | $0.35 | -4,149 | 172.4K | -2% | -$1,452 | |
| 2024-05-06 | 2024-05-02 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres AND CEO, Dir | S - Sale | $0.75 | -3,936 | 176.6K | -2% | -$2,952 | |
| 2024-03-04 | 2024-02-29 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres AND CEO, Dir | S - Sale | $0.89 | -5,834 | 180.5K | -3% | -$5,192 | |
| 2024-02-12 | 2024-02-08 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres AND CEO, Dir | S - Sale | $0.53 | -35.6K | 186.4K | -16% | -$18.9K | |
| 2024-02-05 | 2024-02-01 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres AND CEO, Dir | A - Grant | $0.00 | +62.5K | 226.9K | +38% | $0 | |
| 2024-02-05 | 2024-02-01 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres AND CEO, Dir | S - Sale | $0.55 | -4,981 | 221.9K | -2% | -$2,740 | |
| 2023-11-03 | 2023-11-02 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres, CEO, Dir | S - Sale | $1.22 | -3,796 | 164.4K | -2% | -$4,631 | |
| 2023-08-04 | 2023-08-03 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres, CEO, Dir | S - Sale | $3.07 | -4,307 | 168.2K | -2% | -$13.2K | |
| 2023-05-09 | 2023-05-05 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres, CEO, Dir | S - Sale | $4.40 | -3,869 | 172.5K | -2% | -$17.0K | |
| 2023-03-07 | 2023-03-03 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres, CEO, Dir | S - Sale | $9.71 | -5,987 | 176.4K | -3% | -$58.1K | |
| 2023-02-03 | 2023-02-02 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres, CEO, Dir | S - Sale | $11.80 | -4,191 | 182.4K | -2% | -$49.5K | |
| 2022-11-18 | 2022-11-16 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres, CEO, Dir | S - Sale | $11.13 | -14.5K | 186.6K | -7% | -$161.1K | |
| 2022-04-05 | 2022-04-04 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres, CEO, Dir | S - Sale | $12.67 | -2,006 | 201.0K | -1.0% | -$25.4K | |
| D | 2022-03-01 | 2022-02-25 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Pres, CEO, Dir | A - Grant | $0.00 | +39.0K | 203.0K | +24% | $0 |
| DM | 2021-11-03 | 2021-10-29 | TVRD | Tvardi Therapeutics, Inc. | Posner Christopher | Dir, Senior Advisor | A - Grant | $0.00 | +147.9K | 22.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations